View Older Stories View More Recent Stories
-
Harpoon Therapeutics Announces Closing of Public Offering of Common Stock
-
Knowles Corp (KN) PT Raised to $23 at Roth Capital, Following Earnings
-
Remark Media (MARK) PT Raised to $5.25 at Roth Capital
-
Applied DNA Sciences (APDN) Prices 1.81M Share Registered Direct Offering at $8.30/Sh
-
Applied DNA Announces Pricing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Humanigen (HGEN) Announces Partnership to Commercialize Nasal Spray that Fights COVID Cytokine Storm, Expects EUA - Roth Capital
-
KemPharm (KMPH) Prices 7.69M Share Common and Warrant Offering at $6.50/Sh
-
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
-
Ideanomics CEO Alf Poor to Participate at the FORCE Family Office & Roth Capital Partners EV Symposium on January 8, 2021
-
Blink Charging (BLNK) Announces Pricing of Public Offering of Common Stock for Gross Proceeds of $221.4 million
-
Blink Charging Announces Pricing of its Public Offering of Common Stock for Gross Proceeds of $221.4 million
-
Blink Charging Announces Pricing of its Public Offering of Common Stock for Gross Proceeds of $221.4 million
-
Endeavour Silver Corp (EXK) PT Raised to $6 at Roth Capital After Production and Pricing Beat Expectations
-
McEwen Mining (MUX) PT Raised to $2 at Roth Capital After Update was Less Bad
-
InvestorNewsBreaks – Atara Biotherapeutics Inc. (NASDAQ: ATRA) Secures $175M in Underwritten Public Offering
-
InvestorNewsBreaks – Asure Software Inc. (NASDAQ: ASUR) Closes Public Offering of $18.9 Million
-
InvestorNewsBreaks – LivePerson Inc. (NASDAQ: LPSN) Closes $517.5M Convertible Senior Notes Offering
-
OptimizeRX (OPRX) PT Raised to Street High $70 at Roth Capital
-
INVO Bioscience Management Letter to Shareholders
-
Harpoon Therapeutics Inc. (HARP) Prices 5.88M Share Common Offering at $17/Sh
-
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
-
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
-
Harpoon Therapeutics Inc. (HARP) Announces Proposed Public Offering of Common Stock
-
Harpoon Therapeutics Announces Proposed Public Offering of Common Stock
-
Harpoon Therapeutics Announces Proposed Public Offering of Common Stock
-
InvestorNewsBreaks – Cellectar Biosciences Inc. (NASDAQ: CLRB) Secures $45M in Underwritten Public Offering and Concurrent Private Placement
-
XL Fleet to Participate in Upcoming Virtual Investor Conferences
-
UPDATE: Roth Capital Resumes Vista Outdoor (VSTO) at Buy
-
Clearside Biomedical (CLSD) Announces Pricing of $12 Million Registered Direct Offering
-
Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering
-
Marker Therapeutics (MRKR) AML Trial Expected to Begin in 2021 - Roth Capital
-
Immunic Inc. (IMUX) Phase 2 Data Confirmed to be in 1Q21 - Roth Capital
-
GreenCarNewsBreaks – Ideanomics (NASDAQ: IDEX) Announces Agreement to Acquire Utah-Based Wireless Charging Provider WAVE
-
Ideanomics (IDEX) to Acquire Utah-based Wireless Charging Provider WAVE
-
Ideanomics Signs a Definitive Agreement to Acquire Utah-based Wireless Charging Provider WAVE
-
Energous Corporation Completes $40 Million At-The-Market Equity Offering
-
Northern Genesis Acquisition Corp. Announces Filing by The Lion Electric Company of a Preliminary Registration Statement on SEC Form F-4 in Connection With Their Proposed Business Combination
-
Ambarella (AMBA) PT Raised to $95 at Roth Capital
-
Silicon Labs (SLAB) PT Raised to $140 at Roth Capital
-
Rambus Inc. (RMBS) PT Raised to $21 at Roth Capital
-
MaxLinear (MXL) PT Raised to $50 at Roth Capital
-
SiTime Corp. (SITM) PT Raised to $130 at Roth Capital
-
Akoustis Technologies (AKTS) PT Raised to $16 at Roth Capital
-
InvestorNewsBreaks – Cambium Networks Corporation (NASDAQ: CMBM) Announces $70 Million Secondary Follow-On
-
Cellectar Biosciences Announces Closing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Fathom Holdings Inc. (FTHM) PT Raised to Street High $40 at Roth Capital
-
Enphase Energy (ENPH) PT Raised to Street High $220 at Roth Capital
-
Cellectar Biosciences (CLRB) Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
Cellectar Biosciences Announces Pricing of $24.5 Million Underwritten Public Offering and $20.5 Million Concurrent Private Placement
-
ReneSola (SOL) Announces Proposed 2.105M ADS Registered Direct Offering at $9.50/Sh

